| [1] | Qin YIN, Zhaorong WU, Feng ZHANG, Chunyan JIN, Yanping CAO, Jiangqiang XIAO, Yuzheng ZHUGE, Qian WANG. Risk factors for unplanned readmission after transjugular intrahepatic portosystemic shunt in cirrhotic patients with esophagogastric variceal bleeding and construction of a nomogram model[J]. Journal of Clinical Hepatology, 2024, 40(9): 1796-1801. doi: 10.12449/JCH240913 |
| [2] | Xinyi LI, Jiaojiao LI, Wei SUN. Establishment and evaluation of a nomogram prediction model for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2024, 40(8): 1605-1611. doi: 10.12449/JCH240816 |
| [3] | Journal of Hepatology｜Association of food insecurity with the prevalence and liver-related mortality of metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. Journal of Clinical Hepatology, 2024, 40(10): 2126-2126. doi: 10.12449/JCH2410.gwqkjpwzjj3 |
| [4] | Hepatology International｜Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2024, 40(2): 270-270. doi: 10.12449/JCH2402.gwqkjpwzjj2 |
| [5] | Lanjing WANG, Jianping QIN, Xin YAO, Qi QI, Lin LIU, Shanhong TANG. Construction of a risk prediction model for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatitis B cirrhosis and portal hypertension[J]. Journal of Clinical Hepatology, 2024, 40(6): 1149-1155. doi: 10.12449/JCH240613 |
| [6] | Hepatology International｜3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study[J]. Journal of Clinical Hepatology, 2024, 40(1): 128-128. doi: 10.12449/JCH2401.gwqkjpwzjj2 |
| [7] | Hui LI, Zhibo XIA, Nianjun XIAO, Jianguo CHU, Shoubin NING, Zheyi HAN. Current research status of prognostic models for transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2023, 39(5): 1191-1196. doi: 10.3969/j.issn.1001-5256.2023.05.030 |
| [8] | Bin XIONG, Chongtu YANG. Association between transjugular intrahepatic portosystemic shunt and sarcopenia in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1541-1546. doi: 10.3969/j.issn.1001-5256.2023.07.005 |
| [9] | Yuyi LIU, Zhiyong MU, Lu HU, Jun WANG, Wei XIONG, Hong HU, Aimin LIU, Xuan AN, Yuqiang XU, Haodong YU, Jinneng WANG, Liangzhi WEN, Dongfeng CHEN. Value of different scoring models in predicting the survival of patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2023, 39(3): 590-598. doi: 10.3969/j.issn.1001-5256.2023.03.016 |
| [10] | Qin LIU, Xin YAO, Ying LI, Sheng HE, Shanhong TANG, Jianping QIN. Bacteremia in an elderly patient with cirrhotic after transjugular intrahepatic portosystemic shunt: A case report[J]. Journal of Clinical Hepatology, 2022, 38(10): 2337-2340. doi: 10.3969/j.issn.1001-5256.2022.10.025 |
| [11] | Hepatology｜Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS[J]. Journal of Clinical Hepatology, 2022, 38(9): 2187-2187. doi: 10.3969/j.issn.1001-5256.2022.09.gwjpwzjj6 |
| [12] | Hepatology｜Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial[J]. Journal of Clinical Hepatology, 2022, 38(10): 2285-2285. doi: 10.3969/j.issn.1001-5256.2022.10.gwjpwzjj2 |
| [13] | Zhang XiaoFeng, Zhang Wei, Yu ZhiYuan, Zhu GeYuZheng. Prognostic and risk factors for patients undergoing recanalization due to shunt dysfunction after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2020, 36(2): 338-342. doi: 10.3969/j.issn.1001-5256.2020.02.021 |
| [14] | 凃 JingJing, XIAO JiangQiang, ZHANG Feng, ZHU GeYuZheng. Causes of death after transjugular intrahepatic portosystemic shunt in patients with hepatic sinusoidal obstruction syndrome[J]. Journal of Clinical Hepatology, 2020, 36(12): 2751-2755. doi: 10.3969/j.issn.1001-5256.2020.12.022 |
| [15] | Wang Zhong, Liu FuQuan. Research advances in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2019, 35(12): 2824-2827. doi: 10.3969/j.issn.1001-5256.2019.12.040 |
| [16] | Jiang MingYuan, Huang Hua, Lu MingLiang, Lin FanYu, Zhang YingYuan. Application of anticoagulants after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(10): 2241-2244. doi: 10.3969/j.issn.1001-5256.2018.10.040 |
| [18] | Ren ShuYao, Chen Hui, Lu: Yong, Wang ZhengYu, Niu Jing, Yin ZhanXin, He ChuangYe, Guo WenGang, Han GuoHong. Hepatic myelopathy after transjugular intrahepatic portosystemic shunt:natural course,survival analysis,and treatment[J]. Journal of Clinical Hepatology, 2016, 32(6): 1112-1117. doi: 10.3969/j.issn.1001-5256.2016.06.018 |
| [19] | Xu ZhengGuo, Zhao YongBing, Zheng YuanYu, Liu En, Yang ShiMing. Association between portal vein pressure drop gradient after transjugular intrahepatic portosystemic shunt and clinical prognosis[J]. Journal of Clinical Hepatology, 2016, 32(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2016.12.019 |
DownLoad: